McKesson Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from McKesson Corporation's yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 7.2 times. Higher than 92% of Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $2 per $100 of sales comes from others' credit, against $1 from others' credit three years earlier. Less money tied up than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
7.2×Over the last 3 years its own operating cash covered its investment spending (capex) 7.2 times.
Higher than 92% of Healthcare companies in United States.
Cash Locked Ratio
−$2Money owed to suppliers is larger than money owed by customers plus stock: $2 per $100 of sales comes from others' credit, against $1 from others' credit three years earlier.
Less money tied up than 91% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$1Sales grew 46% in 3 years; of every extra $100 of sales, $1 became extra profit.
Lower than 66% of Healthcare companies in United States.
Asset Productivity Ratio
+46% / +32%In 3 years sales changed by +46% while total assets changed by +32%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
4.9×Debt due within a year is covered 4.9 times by its yearly operating cash.
Higher than 80% of Healthcare companies in United States.
Cash Cushion Ratio
−4%Debt, after subtracting cash, equals 4% of its market value (net debt).
Lower than 73% of Healthcare companies in United States.
Tangible Assets Ratio
81%Of every $100 the company owns, $81 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 51% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
McKesson Corporation owes $1.01 for every $1 it owns. Net profit rose 45% in the year to Mar 2026, and grew 10% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Mar 2026.
P/E ratio
26.9Investors pay $26.9 for every $1 of McKesson Corporation's yearly profit, lower than 51% of Healthcare companies in United States.
P/B ratio
-27.52McKesson Corporation's book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$116.7 BThe total market value of all of McKesson Corporation's shares at today's price (share price × number of shares), larger than 98% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
NegativeMcKesson Corporation's net worth is negative ($4.2 B below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.01×McKesson Corporation owes $1.01 for every $1 it owns, so it owes more than it owns, higher than 87% of Healthcare companies in United States.
Dividend yield
0.37%McKesson Corporation pays 0.37% of its share price as dividends a year, lower than 87% of dividend-paying Healthcare companies in United States.
Revenue growth
+12%Revenue rose 12% in the year to Mar 2026, and grew 13% a year on average over 3 years.
Profit growth
+45%Net profit rose 45% in the year to Mar 2026, and grew 10% a year on average over 3 years.
Profit margin
1.2%McKesson Corporation keeps $1 of every $100 of revenue as net profit.
Cash quality
1.3×Cash from McKesson Corporation's business was 1.3× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
26.1×McKesson Corporation's operating profit covered its interest costs 26.1 times in the year to Mar 2026.
Cash vs debt
Net debtMcKesson Corporation had $4.6 B more debt than cash (net debt) at Mar 2026.
Questions
What is McKesson Corporation's P/E ratio?
Investors pay $26.9 for every $1 of McKesson Corporation's yearly profit, lower than 51% of Healthcare companies in United States.
How much does McKesson Corporation owe compared with what it owns?
McKesson Corporation owes $1.01 for every $1 it owns, so it owes more than it owns, higher than 87% of Healthcare companies in United States.
Does McKesson Corporation pay a dividend?
Yes. McKesson Corporation pays 0.37% of its share price as dividends a year, lower than 87% of dividend-paying Healthcare companies in United States.
Is McKesson Corporation's revenue growing?
Revenue rose 12% in the year to Mar 2026, and grew 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.